Easton Pharmaceuticals Launches New Hemp-based Product
February 27th, 2014
News, Top Story
Easton Pharmaceuticals Inc. (OTC: EAPH), a specialty pharmaceutical company that owns, designs, develops, and markets an array of topically-delivered drugs and therapeutic/cosmetic healthcare products, announced the launch of a new hemp-based product that will be marketed and distributed through Hemp Life Today (www.hemplifetoday.com). The anti ageing skin moisturizer product was designed by Easton pharmaceuticals to combat and prevent premature ageing and sun damaged skin using recently-legalized hemp oil as a base.
Read the entire press release discussing the new product launch here:
Easton Pharmaceuticals Inc. (OTC: EAPH), a specialty pharmaceutical company that owns, designs, develops, and markets an array of topically-delivered drugs and therapeutic / cosmetic healthcare products, today announces its has designed and launched its new Hemp based product, Hempstral SA, and has reached an agreement with Hemp Life Today, LLC, a wholly owned subsidiary of Global Links Corp. Hemp Life Today will assist in developing a marketing and distribution program as well as both companies jointly developing a new line of innovative Hemp based products to be marketed on the HempLifeToday.com website, for US and global distribution.
This agreement between Hemp Life Today, LLC and Easton Pharmaceuticals will allow both companies to be better positioned and place them at the forefront of developing, marketing and worldwide distribution of Hemp based and other type of products utilizing the HempLifeToday.com website. The first Hemp product will be introduced at the Total Health Show in April with the showcasing of Easton’s newly developed Hempstral SA, an anti ageing skin moisturizer product designed by Easton pharmaceuticals to combat and prevent premature ageing and sun damaged skin. Hempstral SA consists of high quality hemp oil, which can now be legally obtained from US based producers following changes in federal and state laws. Hempstral SA will be transdermally delivered through skin tissue using Easton’s pharmaceuticals transdermal delivery matrix and formulations, which are patented and / or patent pending, utilized in various other products. Other Hemp based and traditional type products are expected to be introduced which will involve the expertise of Easton Pharmaceuticals to design products, and Hemp Life Today to effectively market, distribute and drive sales.
“We are very excited with our new relationship entered into between Easton pharmaceuticals and Hemp Life Today. We look forward to featuring these amazing new Hemp based products on our site,” stated Tim Zorn, President of HempLifeToday.com. With Hempstral SA and other subsequent products, both companies will be tapping into each other’s expertise. Easton will design products, while Hemp Life Today will provide branding, marketing and distribution.”
Carla Pepe, corporate secretary and marketing director of Easton Pharmaceuticals, commented, “We at Easton Pharmaceuticals are looking forward to be working with Hemp Life Today to utilize their marketing program to ultimately drive sales for Hempstral SA and other subsequent products.”
Hempstral SA is to be introduced in April at the Total health Show, held in Toronto on April 2, 3 and 4 along with VIORRA and its new wound healing and bed sore product, anticipated to be officially unveiled prior to the Total Health Show.
In other news, Easton Pharmaceuticals has replaced its current website contractor and hired the services of another website and branding consultant to revamp its website including corporate logo’s and logo’s of various other products. Additional updates on all of its Medical Marijuana initiatives, its ongoing negotiations, and its discussions with an expected manufacturing agreement in Mexico for Viorra to be shortly announced or as they become available.
For More Information Visit:
For More Information On Global Links Corp. / HempLifeToday.com Visit
This news release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 (The “Act”). In particular, when used in the preceding of discussion, the words “anticipate,” “pleased,” “plan,” “confident that,” “believe,” “expect,” “possible” or “intent to” and similar conditional expressions are intended to identify forward-looking statements within the meaning of the Act and are subject to the safe harbor created by the Act. Such statements are subject to certain risks and uncertainties and actual results could differ materially from those expressed in any of the forward-looking statements. Such risks and uncertainties include, but are not limited to, market conditions, general acceptance of the company’s products and technologies, competitive factors, the ability to successfully complete additional or adequate financing, government approvals or changes to proposed laws and other risks and uncertainties further stated in the company’s financial reports and filings.
This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
Follow Us on Social Media
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.